Back to results
US 11,685,791 B2Granted
Antibody binding specifically to N-terminal region of lysyl-tRNA synthetase exposed on cell membrane
AssigneeZymedi Co., Ltd.
InventorsSunghoon Kim, Hyunbo Shim, Nam Hoon Kwon, Daeyoung Han
Life of this patent
Estimating the term…
Abstract
The present invention relates to an antibody binding specifically to an N-terminal region of lysyl-tRNA synthetase which is exposed on the cell membrane and a use thereof.
Claims8
An antibody or fragment thereof specifically binding to an epitope consisting of a sequence of SEQ ID NO:
- 101, SEQ ID NO:
- 106, or SEQ ID NO:
- 111 in the lysyl-tRNA synthetase (KRS) N-terminus, wherein the antibody or fragment thereof specifically binds to an extracellularly exposed lysyl-tRNA synthetase (KRS) N-terminal region, wherein the antibody or fragment thereof comprises a heavy chain variable region and a light chain variable region which are selected from the group consisting of:
- a heavy chain variable region comprising heavy chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO:
- 1, heavy chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO:
- 3, and heavy chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO:
- 5, and a light chain variable region comprising light chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO:
- 7, light chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO:
- 9, and light chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO:
- 11;
- a heavy chain variable region comprising heavy chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO:
- 13, heavy chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO:
- 15, and heavy chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO:
- 17, and a light chain variable region comprising light chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO:
- 19, light chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO:
- 21, and light chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO:
- 23;
- a heavy chain variable region comprising heavy chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO:
- 25, heavy chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO:
- 27, and heavy chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO:
- 29, and a light chain variable region comprising light chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO:
- 31, light chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO:
- 33, and light chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO:
- 35;
- and
- a heavy chain variable region comprising heavy chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO:
- 37, heavy chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO:
- 39, and heavy chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO:
- 41, and a light chain variable region comprising light chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO:
- 43, light chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO:
- 45, and light chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO:
- 47.
29 more elements
Dependencies are inferred from the claim text.